Biography:
Dr. Im Sampen is a Principal Investigator funded by NIH, the Department of Defense (DoD), Veterans Affairs (VA) and Foundations as a multidisciplinary osteoarthritis (OA) pain research group. Her research has been instrumental in establishing preclinical rodent models to examine mutual cause-and-effect relationships in OA that link tissue degeneration with pain. She has served on multiple NIH and Foundation study sections administered by NIAMS, VA, or international funding agencies. She also served as an Editor-In-Chief for Gene Reports or Executive Editor (Gene) and an Editorial board member of numerous international journals. She has been a member of the Orthopaedic Research Society (ORS) since 2000 and served the ORS as Nominating Committee (elected), an Executive Member of Women’s Leadership Forum and Asian Leadership Forum member. She received various awards and honors, such as the Arthritis National Research Foundation Scholar Award, OARSI Investigator Award, Kappa Delta Elizabeth Winston Lanier Award from the ORS, and VA Research Scientist Award.Dr. Im Sampen is a Principal Investigator funded by NIH, the Department of Defense (DoD), Veterans Affairs (VA) and Foundations as a multidisciplinary osteoarthritis (OA) pain research group. Her research has been instrumental in establishing preclinical rodent models to examine mutual cause-and-effect relationships in OA that link tissue degeneration with pain. She has served on multiple NIH and Foundation study sections administered by NIAMS, VA, or international funding agencies. She also served as an Editor-In-Chief for Gene Reports or Executive Editor (Gene) and an Editorial board member of numerous international journals. She has been a member of the Orthopaedic Research Society (ORS) since 2000 and served the ORS as Nominating Committee (elected), an Executive Member of Women’s Leadership Forum and Asian Leadership Forum member. She received various awards and honors, such as the Arthritis National Research Foundation Scholar Award, OARSI Investigator Award, Kappa Delta Elizabeth Winston Lanier Award from the ORS, and VA Research Scientist Award.
Title : A single intraarticular injection of nanotechnology-based drug formulation as a safe osteoarthritis disease- modifying drug.
Title : The intervention of OA and comorbid depressive disorder by a selective combination of pro/prebiotic treatment